Post-authorization safety of COVID-19 vaccine: A prospective and observational study among health-care workers in Tumakuru
National Journal of Physiology, Pharmacy and Pharmacology
; 12(9):1516-1520, 2022.
Article
in English
| ProQuest Central | ID: covidwho-2025152
ABSTRACT
The World Health Organization declared the virus a Public Health Emergency of International Concern on January 30, 2020, and later a pandemic on March 11, 2020. Since 2021, variants of the virus have resulted in further waves in several countries, with the delta variant being the most virulent. Following Ethics Committee approval and permission from District Health Officer (DHO), Tumkur, Karnataka, contact details of (either gender;age >25 years) 2650 health-care workers (ASHA, Clerical/Administrative Staff, Medical Officers, Nurses and Supervisors Others, Para Medical Staff, Students, and Support Staff) who had received first dose of Covisheild vaccine and willing to respond were enrolled for the study during February 2021. Through telecalling, health-care workers demographic data (age, gender, and comorbidities) and any type of adverse reactions (fever, headache, myalgia, pain at the injection site, or any other specified symptoms using the WHObased adverse event following immunization (AEFI) form) following first dose of vaccination (after 30 min of observation period) were noted. [...]dose was received by only 98% of the participants.
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
National Journal of Physiology, Pharmacy and Pharmacology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS